Clinical Trial

Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

Study acronym: BLOCT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-06.
Status change: Not Yet Recruiting → Recruiting 2024-12-04
Trial Details
NCT Number NCT06679920
Lead Sponsor Amsterdam UMC
Conditions Bladder Cancer
Enrollment 15 participants
Start Date 2024-12
Primary Completion 2025-03 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2024-12-06